Outbreaks of Adenovirus-associated Respiratory Illness on 5 College Campuses in the United States, 2018-2019.
adenovirus
colleges
outbreak
respiratory illness
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
received:
14
01
2020
accepted:
21
04
2020
pubmed:
24
4
2020
medline:
6
7
2021
entrez:
24
4
2020
Statut:
ppublish
Résumé
Human adenoviruses (HAdVs) are commonly associated with acute respiratory illness. HAdV outbreaks are well documented in congregate military training settings, but less is known about outbreaks on college campuses. During fall 2018 and spring 2019, 5 United States (US) colleges reported increases in HAdV-associated respiratory illness. Investigations were performed to better understand HAdV epidemiology in this setting. A case was defined as a student at one of the 5 colleges, with acute respiratory illness and laboratory-confirmed HAdV infection during October 2018-December 2018 or March-May 2019. Available respiratory specimens were typed by HAdV type-specific real-time polymerase chain reaction assays, and for a subset, whole genome sequencing was performed. We reviewed available medical records and cases were invited to complete a questionnaire, which included questions on symptom presentation, social history, and absenteeism. We identified 168 HAdV cases. Median age was 19 (range, 17-22) years and 102 cases (61%) were male. Eleven cases were hospitalized, 10 with pneumonia; 2 cases died. Among questionnaire respondents, 80% (75/94) missed ≥ 1 day of class because of their illness. Among those with a type identified (79%), HAdV types 4 and 7 were equally detected, with frequency of each varying by site. Genome types 4a1 and 7d were identified, respectively, by whole genome sequence analysis. HAdV respiratory illness was associated with substantial morbidity and missed class time among young, generally healthy adults on 5 US college campuses. HAdVs should be considered a cause of respiratory illness outbreaks in congregate settings such as college campuses.
Sections du résumé
BACKGROUND
Human adenoviruses (HAdVs) are commonly associated with acute respiratory illness. HAdV outbreaks are well documented in congregate military training settings, but less is known about outbreaks on college campuses. During fall 2018 and spring 2019, 5 United States (US) colleges reported increases in HAdV-associated respiratory illness. Investigations were performed to better understand HAdV epidemiology in this setting.
METHODS
A case was defined as a student at one of the 5 colleges, with acute respiratory illness and laboratory-confirmed HAdV infection during October 2018-December 2018 or March-May 2019. Available respiratory specimens were typed by HAdV type-specific real-time polymerase chain reaction assays, and for a subset, whole genome sequencing was performed. We reviewed available medical records and cases were invited to complete a questionnaire, which included questions on symptom presentation, social history, and absenteeism.
RESULTS
We identified 168 HAdV cases. Median age was 19 (range, 17-22) years and 102 cases (61%) were male. Eleven cases were hospitalized, 10 with pneumonia; 2 cases died. Among questionnaire respondents, 80% (75/94) missed ≥ 1 day of class because of their illness. Among those with a type identified (79%), HAdV types 4 and 7 were equally detected, with frequency of each varying by site. Genome types 4a1 and 7d were identified, respectively, by whole genome sequence analysis.
CONCLUSIONS
HAdV respiratory illness was associated with substantial morbidity and missed class time among young, generally healthy adults on 5 US college campuses. HAdVs should be considered a cause of respiratory illness outbreaks in congregate settings such as college campuses.
Identifiants
pubmed: 32322889
pii: 5823941
doi: 10.1093/cid/ciaa465
pmc: PMC8315123
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1992-1999Subventions
Organisme : NCEZID CDC HHS
ID : U50 CK000375
Pays : United States
Informations de copyright
Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Références
J Infect Dis. 2006 Oct 1;194(7):877-85
pubmed: 16960774
Emerg Infect Dis. 2018 Nov;24(11):2117-2119
pubmed: 30334721
Virol J. 2019 Jun 13;16(1):78
pubmed: 31196108
Emerg Infect Dis. 2012 Mar;18(3):507-9
pubmed: 22377242
Open Forum Infect Dis. 2019 Jan 11;6(2):ofz017
pubmed: 30800698
J Clin Microbiol. 2015 Feb;53(2):746-9
pubmed: 25520444
Clin Infect Dis. 2014 Oct;59(7):962-8
pubmed: 24991024
Clin Infect Dis. 2006 Aug 1;43(3):331-9
pubmed: 16804849
Emerg Infect Dis. 2017 Jan;23(1):95-98
pubmed: 27748651
J Med Case Rep. 2011 Jun 30;5:259
pubmed: 21718493
MMWR Recomm Rep. 2000 Jun 30;49(RR-7):13-20
pubmed: 10902835
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Blood. 2010 Dec 16;116(25):5476-85
pubmed: 20837781
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Emerg Infect Dis. 2017 Jul;23(7):1194-1197
pubmed: 28628451
JAMA. 2001 Aug 8;286(6):688-93
pubmed: 11495618
Virology. 2010 Sep 1;404(2):180-6
pubmed: 20627349
Virus Res. 2019 Sep;270:197662
pubmed: 31301331
Bone Marrow Transplant. 2003 Mar;31(6):481-6
pubmed: 12665844
MSMR. 2019 Feb;26(2):21-27
pubmed: 30807199
Clin Infect Dis. 2002 Mar 1;34(5):577-82
pubmed: 11803503
Sci Rep. 2016 Nov 16;6:37216
pubmed: 27848998
Clin Microbiol Rev. 2014 Jul;27(3):441-62
pubmed: 24982316
Emerg Infect Dis. 2016 Jun;22(6):1044-51
pubmed: 27191834
Vaccine. 2013 Jun 19;31(28):2963-71
pubmed: 23623865
PLoS One. 2015 Apr 15;10(4):e0122642
pubmed: 25875735
J Infect Dis. 2020 Feb 18;221(5):697-700
pubmed: 30783668
Emerg Infect Dis. 2018 Feb;24(2):201-209
pubmed: 29350143
Biol Blood Marrow Transplant. 2007 Jan;13(1):74-81
pubmed: 17222755
Am J Epidemiol. 1973 Mar;97(3):187-98
pubmed: 4348245
Transpl Infect Dis. 2012 Dec;14(6):555-63
pubmed: 23146063
Arch Virol. 1988;101(1-2):65-77
pubmed: 2843149
J Clin Microbiol. 2013 Apr;51(4):1089-93
pubmed: 23325827
Antiviral Res. 2019 Mar;163:50-58
pubmed: 30677427
J Virol. 1986 Oct;60(1):331-5
pubmed: 3018298
MMWR Morb Mortal Wkly Rep. 2017 Oct 06;66(39):1039-1042
pubmed: 28981484
U S Armed Forces Med J. 1956 Dec;7(12):1717-25
pubmed: 13392173
Vaccine. 2006 Apr 5;24(15):2835-42
pubmed: 16480793
MMWR Recomm Rep. 2005 May 27;54(RR-7):1-21
pubmed: 15917737
Sci Rep. 2014 Dec 08;4:7365
pubmed: 25482188